Olopatadine nasal spray 0.6%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Olopatadine nasal spray 0.6%, covering 2011-05-10 to 2011-05-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis [Phase 4]